Seagen Inc - ESG Rating & Company Profile powered by AI
The page contains a zero-cost Sustainability assessment covering Seagen Inc. The dashboard contains a Q&A table about Seagen Inc. Scroll down to the bottom of the webpage for potential risks for Seagen Inc based on sector, location and size.
Seagen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 2.0, social score of 6.0 and governance score of 4.6.
4.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 951 | Purple Biotech Ltd | 4.3 | High |
| 951 | Vectura Group Services Ltd | 4.3 | High |
| 969 | Seagen Inc | 4.2 | High |
| 969 | Botanix Pharmaceuticals Ltd | 4.2 | High |
| 969 | Arvinas Inc | 4.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Seagen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Seagen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Seagen Inc report the average age of the workforce?
Sign up for free to unlockDoes Seagen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Seagen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Seagen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Seagen Inc offer flexible work?
Sign up for free to unlockDoes Seagen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Seagen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Seagen Inc conduct supply chain audits?
Sign up for free to unlockDoes Seagen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Seagen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Seagen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Seagen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Seagen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Seagen Inc disclose water use targets?
Sign up for free to unlockDoes Seagen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Seagen Inc have a product recall in the last two years?
Sign up for free to unlockDoes Seagen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Seagen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Seagen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Seagen Inc disclose parental leave metrics?
Sign up for free to unlockDoes Seagen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Seagen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Seagen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Seagen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Seagen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Seagen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Seagen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Seagen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Seagen Inc disclose its waste policy?
Sign up for free to unlockDoes Seagen Inc report according to TCFD requirements?
Sign up for free to unlockDoes Seagen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Seagen Inc disclose energy use targets?
Sign up for free to unlockDoes Seagen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Seagen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Seagen Inc
These potential risks are based on the size, segment and geographies of the company.
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.